Age Moderates the Impact of TRAbs on Thyroid Hormones and Hepatic Function in Patients with Graves' Disease

被引:2
|
作者
Guo, Kai [1 ]
Ling, Hongwei [2 ]
Zhou, Xiaoyan [1 ]
Ying, Changjiang [2 ]
机构
[1] Xuzhou Med Univ, Grad Sch, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Endocrinol, Affiliated Hosp, 99 West Huai Hai Rd, Xuzhou 221000, Jiangsu, Peoples R China
基金
俄罗斯科学基金会;
关键词
Graves' disease; thyrotropin receptor antibodies; thyroid hormone; hepatic function; LIVER-FUNCTION TESTS; THYROTROPIN RECEPTOR; INCREASED MORTALITY; SERIAL CHANGES; HYPERTHYROIDISM; DYSFUNCTION; MITOCHONDRIA; PREVALENCE; MANAGEMENT; DIAGNOSIS;
D O I
10.1055/a-1510-9100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyrotropin receptor antibodies (TRAbs) play a significant role in the course of hepatic dysfunction (HDF) in patients with Graves' disease (GD). However, few studies have considered the factors that influence the relationships among TRAbs, thyroid hormone levels, and hepatic function in subjects with newly diagnosed GD. Here we investigated the associations of TRAbs with thyroid hormones and hepatic function and assessed potential factors that can influence these associations among patients with GD. A total of 368 patients newly diagnosed with GD were collected in this cross-sectional study. Patients who had received antithyroid drugs, radioactive iodine, or surgery were excluded. Levels of TRAbs and thyroid hormones and hepatic function were recorded. Linear and binary logistic regression analysis models were applied to investigate associations among these variables after adjusting for confounding characteristics. There was a significant difference in TRAbs indices between the HDF and normal hepatic function groups (p <0.05). After adjusting for confounders, the relationship between TRAbs and thyroid hormones was nonlinear, showing a curve with an initial positive slope and a subsequent flattening (p <0.05). Higher TRAbs were associated with HDF [odds ratio (OR) 1.036, 95% confidence interval (CI) 1.018-1.053 per 1-IU/l increase]. These associations were modified by age, but not by gender, smoking status, Graves' orbitopathy, thyroid-peroxidase antibody levels, or thyroglobulin antibody levels. In younger patients, increasing TRAbs were correlated with higher thyroid hormones and HDF (OR 1.034, 95% CI 1.017-1.052) per1-IU/l increase). In older patients, TRAbs were not correlated with thyroid hormones or HDF (OR 1.024, 95% CI 0.993-1.056) per 1-IU/l increase. Age can affect the impact of TRAbs on thyroid hormone levels and hepatic function in GD. TRAb measurement can have good predictive value in younger patients.
引用
收藏
页码:453 / 460
页数:8
相关论文
共 50 条
  • [41] Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis
    de Morais, Nathalie Silva
    Angell, Trevor E.
    Ahmadi, Sara
    Alexander, Erik K.
    dos Santos Teixeira, Patricia de Fatima
    Marqusee, Ellen
    ENDOCRINE PRACTICE, 2022, 28 (05) : 502 - 508
  • [42] Impact of thyroid disease on testicular function
    Sandro La Vignera
    Roberto Vita
    Rosita A. Condorelli
    Laura M. Mongioì
    Silvia Presti
    Salvatore Benvenga
    Aldo E. Calogero
    Endocrine, 2017, 58 : 397 - 407
  • [43] Impact of thyroid function screening in a large cohort of patients admitted to an emergency department
    Campi, Irene
    Perego, Giovanni Battista
    Ravogli, Antonella
    Santafede, Francesca
    Sileo, Federica
    Dubini, Antonella
    Parati, Gianfranco
    Persani, Luca
    Fugazzola, Laura
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (08) : 2379 - 2389
  • [44] Graves' Disease and Thymic Hyperplasia: The Relationship of Thymic Volume to Thyroid Function
    Popoveniuc, Geanina
    Sharma, Meeta
    Devdhar, Madhuri
    Wexler, Jason A.
    Carroll, Nancy M.
    Wartofsky, Leonard
    Burman, Kenneth D.
    THYROID, 2010, 20 (09) : 1015 - 1018
  • [45] Impact of thyroid disease on testicular function
    La Vignera, Sandro
    Vita, Roberto
    Condorelli, Rosita A.
    Mongioi, Laura M.
    Presti, Silvia
    Benvenga, Salvatore
    Calogero, Aldo E.
    ENDOCRINE, 2017, 58 (03) : 397 - 407
  • [46] Pediatric Thyroid Carcinoma in Patients with Graves' Disease: The Role of Ultrasound in Selecting Patients for Definitive Therapy
    Kovatch, Kevin J.
    Bauer, Andrew J.
    Isaacoff, Elizabeth J.
    Prickett, Kara K.
    Adzick, N. Scott
    Kazahaya, Ken
    Sullivan, Lisa M.
    Mostoufi-Moab, Sogol
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 83 (06): : 408 - 413
  • [47] High levels of thyroid hormones promote recurrence of Graves' disease via overexpression of B-cell-activating factor
    Liu, Shu
    Miao, Jing-Jing
    Zhou, Xiao
    Sun, Qi
    Mao, Xiao-Ming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (10)
  • [48] Society of Asian Academic Surgeons Incidental Thyroid Cancer in Patients With Graves' Disease: Not as Rare as We Previously Believed
    Moronta, Shaidy
    Slattery, Lauren
    Wang, Rongzhi
    Nwariaku, Fiemu
    Mcmullin, Jessica Liu
    JOURNAL OF SURGICAL RESEARCH, 2025, 308 : 122 - 128
  • [49] Clinical features of moyamoya disease with Graves disease: a retrospective study of 394,422 patients with thyroid disease
    Hiruma, Marino
    Watanabe, Natsuko
    Mitsumatsu, Takako
    Suzuki, Nami
    Fukushita, Miho
    Matsumoto, Masako
    Yoshihara, Ai
    Noh, Jaeduk Yoshimura
    Sugino, Kiminori
    Ito, Koichi
    ENDOCRINE JOURNAL, 2023, 70 (02) : 141 - 148
  • [50] Calcium and its regulating hormones in patients with graves disease: Sex differences and relation to postoperative tetany
    Yamashita, H
    Noguchi, S
    Murakami, T
    Uchino, S
    Watanabe, S
    Ohshima, A
    Kawamoto, H
    Toda, M
    Yamashita, H
    EUROPEAN JOURNAL OF SURGERY, 2000, 166 (12) : 924 - 928